Mahana Therapeutics is a prescription digital therapeutic company (PDT) developing internet and mobile-based treatments for children and adults living with gastrointestinal diseases and conditions. Our first product will be an FDA-cleared PDT for Irritable Bowel Syndrome (IBS).
The company is a diverse mix of healthcare and technology entrepreneurs, gastroenterologists, psychologists, behavioral scientists, and passionate patients looking to improve the health and quality of life of people living with chronic gastrointestinal conditions. Mahana is based in San Francisco, California and London, England and is backed by leading venture capital firms. For more information please visit www.mahanatx.com.